Product Information
DEPO-SUBQ PROVERA 104 SYRINGE is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $77.4278 per ML under NDC 00009470913. Its NADAC has been published 570 times since Nov 28, 2013.
FDA first approved this application on Dec 17, 2004.
The High Outlier badge above means this manufacturer's average price in the medroxyprogesterone acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
104 mg/.65mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009470913
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA021583FDA Approved
12/17/2004
On Market Since
5/2/2005
Pharmacological Classes
Price Statistics
The NADAC for DEPO-SUBQ PROVERA 104 SYRINGE has been published 570 times since Nov 28, 2013, and over the history we have for it it has declined 56.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $77.4278 per ML |
|---|---|
| All-time high | $349.4328 (Jan 16, 2019) |
| All-time low | $77.2219 (Feb 3, 2021) |
| 52-week high | $77.5109 |
| 52-week low | $77.3621 |
| Median price | $77.7556 |
| Average price | $175.9763 |
| Largest weekly change | -77.5% (Feb 3, 2021) |
| Weeks tracked | 570 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the medroxyprogesterone acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEPO-SUBQ PROVERA 104 SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for DEPO-SUBQ PROVERA 104 SYRINGE, manufactured by Pharmacia & Upjohn Company LLC, is $77.4278 per ML (NDC 00009470913), effective Aug 19, 2026.
How has the price of DEPO-SUBQ PROVERA 104 SYRINGE changed over time?
Over the history we have for it, the NADAC for DEPO-SUBQ PROVERA 104 SYRINGE has declined 56.9%. It has been tracked across 570 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DEPO-SUBQ PROVERA 104 SYRINGE?
Since Nov 28, 2013, the NADAC for DEPO-SUBQ PROVERA 104 SYRINGE has ranged from a low of $77.2219 (Feb 3, 2021) to a high of $349.4328 (Jan 16, 2019), with a median of $77.7556 per ML.
Are there cheaper alternatives to DEPO-SUBQ PROVERA 104 SYRINGE?
No other NADAC-published product currently shares the active ingredient and strength of DEPO-SUBQ PROVERA 104 SYRINGE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEPO-SUBQ PROVERA 104 SYRINGE?
DEPO-SUBQ PROVERA 104 SYRINGE (NDC 00009470913) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.